Enkastins: new glycopeptides which act to inhibit enkephlinase,

Details Enkastins: new glycopeptides which act to inhibit enkephlinase, Enkastins: new glycopeptides which act to inhibit enkephlinase,

1991-07-05

1994-04-12

Springer, David B.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 8, 536 292, 530322, C07H 702, A61K 3170

Patent

active

053025822

ABSTRACT:
The invention relates to new biologically active glycopeptides of the general formula

REFERENCES:
Heyns et al., Chemische Brichte Jahrg, vol. 90, pp. 1374-1387 (1957).
Chemical Abstracts, vol. 54, No. 3239e (1959).
P. Finot, Diabetes, vol. 31, Supp. 3, pp. 22-28 (1982).
K. Heyns and H. Paulsen, Liebigs Ann. Chem. 622, (1959) pp. 160-174.
H. Roper et al., Carbohydrate Res. 116, (1983) pp. 183-195.
B. N. Stepaneko and N. N. Borodina, Prikl. Biokhim. Mikrobiol. 12(1), (1976), pp. 5-13.
C. A. 85: 143425h.
R. E. Chipkin, Drugs of the Future, vol. 11, (1986), pp. 593-606.
M. Pozsgay et al., Biochemistry, vol. 25, (1986), pp. 1292-1299.

Affiliated with

Also associated with

Rating

Enkastins: new glycopeptides which act to inhibit enkephlinase, does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enkastins: new glycopeptides which act to inhibit enkephlinase, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enkastins: new glycopeptides which act to inhibit enkephlinase, will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2098742